Leffler H, 2004, Introduction to galectins, Glycoconj J, 19, 422
10.1016/S0304-4165(02)00312-4
10.1016/S1471-4906(02)02232-9
10.1002/(SICI)1521-4141(199808)28:08<2311::AID-IMMU2311>3.0.CO;2-G
10.4049/jimmunol.160.10.4831
10.1182/blood-2006-04-016451
10.1038/labinvest.3700432
10.1182/blood-2007-01-069229
10.1016/j.cytogfr.2007.01.006
10.1093/oxfordjournals.jbchem.a021762
10.4049/jimmunol.176.2.778
10.4049/jimmunol.167.10.5697
10.4049/jimmunol.163.7.3801
10.1016/j.cellsig.2006.02.007
Vespa GN, 1999, Galectin‐1 specifically modulates TCR signals to enhance TCR apoptosis but inhibit IL‐2 production and proliferation, J Immunol, 162, 799, 10.4049/jimmunol.162.2.799
10.4049/jimmunol.165.7.3722
10.1046/j.1365-2567.1999.00746.x
10.1016/j.molimm.2006.02.011
10.1016/S0016-5085(03)00267-1
10.4049/jimmunol.176.10.6323
10.4049/jimmunol.177.8.5278
10.1016/j.clim.2003.08.003
10.1016/S1535-6108(04)00024-8
10.1038/labinvest.3700420
10.4049/jimmunol.177.2.796
10.1016/j.molimm.2006.06.001
10.4049/jimmunol.178.1.436
10.4049/jimmunol.177.1.216
10.4049/jimmunol.176.12.7207
10.1002/(SICI)1521-4141(200005)30:5<1331::AID-IMMU1331>3.0.CO;2-H
10.1016/S0002-9440(10)63507-9
10.1182/blood-2006-03-007153
10.1016/0165-5728(90)90032-I
10.1016/S0304-4165(99)00177-4
10.1016/j.bbrc.2005.10.033
10.1016/j.cub.2005.12.046
10.1023/B:GLYC.0000014088.21242.e0
10.1023/B:GLYC.0000014082.99675.2f
10.1016/S0304-4165(02)00313-6
10.1097/01.MIB.0000225341.37226.7c
Fukumori T, 2003, CD29 and CD7 mediate galectin‐3‐induced type II T‐cell apoptosis, Cancer Res, 63, 8302
10.1016/S0002-9440(10)63177-X
10.1016/S0002-9440(10)64975-9
Harjacek M, 2001, Expression of galectins‐1 and ‐3 correlates with defective mononuclear cell apoptosis in patients with juvenile idiopathic arthritis, J Rheumatol, 28, 1914
10.1016/S0076-6879(06)17018-4
10.1016/S0014-5793(00)01547-7
10.1016/S0300-9084(01)01289-5
10.2353/ajpath.2007.060389
10.4049/jimmunol.156.10.3939
10.4049/jimmunol.168.4.1813
10.1002/(SICI)1521-4141(199809)28:09<2864::AID-IMMU2864>3.0.CO;2-U
10.1016/j.bbrc.2006.12.081
Hsu DK, 1996, Human T lymphotropic virus‐1 infection of human T lymphocytes induces expression of the β‐galactose‐binding lectin, galectin‐3, Am J Pathol, 148, 1661
10.1016/0014-5793(96)01031-9
Liu FT, 1995, Expression and function of galectin‐3, a β‐galactoside‐binding lectin, in human monocytes and macrophages, Am J Pathol, 147, 1016
10.1016/0165-2478(94)90072-8
10.4049/jimmunol.165.4.2156
Cortegano I, 1998, Galectin‐3 down‐regulates IL‐5 gene expression on different cell types, J Immunol, 161, 385, 10.4049/jimmunol.161.1.385
10.4049/jimmunol.177.8.4991
10.2353/ajpath.2006.050636
10.1046/j.1365-2567.1998.00517.x
10.1016/S0002-9440(10)63255-5
10.4049/jimmunol.176.3.1943
Nachtigal M, 1998, Galectin‐3 expression in human atherosclerotic lesions, Am J Pathol, 152, 1199
10.1016/S0006-291X(02)00637-X
Suarez‐Alvarez B, 2001, Circulating IgG response to stromelysin‐3, collagenase‐3, galectin‐3 and mesothelin in patients with pharynx/larynx squamous cell carcinoma, Anticancer Res, 21, 3677
10.4049/jimmunol.170.7.3631
10.1016/j.febslet.2005.02.054
10.4049/jimmunol.168.4.1961
10.1164/rccm.200608-1243OC
10.1016/j.clim.2007.04.015
10.4049/jimmunol.169.10.5912
10.1016/j.biocel.2004.07.014
10.1128/JVI.78.9.4947.2004
10.1111/j.0818-9641.2004.01248.x
10.1111/j.1365-3024.2005.00749.x
10.1023/B:GLYC.0000025817.24297.17
Kasamatsu A, 2005, Galectin‐9 as a regulator of cellular adhesion in human oral squamous cell carcinoma cell lines, Int J Mol Med, 16, 269
10.1158/1078-0432.CCR-04-0861
10.1111/j.1075-122X.2006.00334.x
10.1128/JVI.79.21.13326-13337.2005
10.4049/jimmunol.175.5.2974
Glinsky GV, 1996, Inhibition of human breast cancer metastasis in nude mice by synthetic glycoamines, Cancer Res, 56, 5319
10.1002/1439-7633(20011105)2:11<822::AID-CBIC822>3.0.CO;2-W
10.1016/S0076-6879(03)01050-4
10.1016/j.bmcl.2005.02.079
10.2174/092986706779026219